Drug-elicited systemic allergic (contact) dermatitis - Update and possible pathomechanisms
Thyssen J P, Maibach H I., Drug-elicited systemic allergic (contact) dermatitis-update and possible pathomechanisms. Contact Dermatitis 2008: 59: 195-202.
Partial versus full agonists for opioid-mediated analgesia - Focus on fentanyl and buprenorphine
Zuurmond W W, Meert T F, Noorduin H., Partial versus full agonists for opioid-mediated analgesia-focus on fentanyl and buprenorphine. Acta Anaesthesiol Belg 2002: 53: 193-201. (Pubitemid 36187826)
Transdermal buprenorphine in clinical practice - A post-marketing surveillance study in 13179 patients
DOI 10.1185/030079905X53315, 3003
Griessinger N, Sittl R, Likar R., Transdermal buprenorphine in clinical practice-a post-marketing surveillance study in 13,179 patients. Curr Med Res Opin 2005: 21: 1147-1156. (Pubitemid 41140716)
Callejo Melgosa A M, Martinez J C, Fuentes M J, Martin C., Allergic contact dermatitis from buprenorphine. Allergy 2005: 60: 1217-1218. (Pubitemid 41153158)
Generalized dermatitis due to codeine. Cross-sensitization among opium alkaloids
DOI 10.1111/j.0105-1873.2005.0670h.x
Rodriguez A, Barranco R, Latasa M, de Urbina J J, Estrada J L., Generalized dermatitis due to codeine. Cross-sensitization among opium alkaloids. Contact Dermatitis 2005: 53: 240. (Pubitemid 41499707)
Contact allergy and respiratory/mucosal complaints from heroin (diacetylmorphine)
Hogen Esch A J, van der Heide S, van den Brink W, van Ree J M, Bruynzeel D P, Coenraads P J., Contact allergy and respiratory/mucosal complaints from heroin (diacetylmorphine). Contact Dermatitis 2006: 54: 42-49.